Repeated administration of α7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases α7 nAChR levels in the brain

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Neurochemistry

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1471-4159.2010.06845.xPMID 20533993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology.

  2010cited by this paper
• Distinct neural pathways mediate α7 nicotinic acetylcholine receptor-dependent activation of the forebrain.

  2010cited by this paper
• Activation and Desensitization of Nicotinic α7-type Acetylcholine Receptors by Benzylidene Anabaseines and Nicotine

  2009cited by this paper
• Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug Discovery

  2009cited by this paper
• Distinct neural pathways mediate alpha7 nicotinic acetylcholine receptor-dependent activation of the forebrain

  2009cited by this paper
• Desensitization of Nicotinic Acetylcholine Receptors as a Strategy for Drug Development

  2009cited by this paper
• TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia.

  2009cited by this paper
• Spatial and intracellular relationships between the alpha7 nicotinic acetylcholine receptor and the vesicular acetylcholine transporter in the prefrontal cortex of rat and mouse.

  2009cited by this paper
• Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction.

  2009cited by this paper
• Midbrain dopamine neurons signal preference for advance information about upcoming rewards.

  2009cited by this paper
• Presynaptic α7- and β2-Containing Nicotinic Acetylcholine Receptors Modulate Excitatory Amino Acid Release from Rat Prefrontal Cortex Nerve Terminals via Distinct Cellular Mechanisms

  2008cited by this paper
• Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711.

  2008cited by this paper
• Preclinical Characterization of A‐582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition‐Enhancing Properties

  2008cited by this paper
• THE SELECTIVE α7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST A-582941 ACTIVATES IMMEDIATE EARLY GENES IN LIMBIC REGIONS OF THE FOREBRAIN : DIFFERENTIAL EFFECTS IN THE JUVENILE AND ADULT RAT

  2008cited by this paper
• Presynaptic type III neuregulin1-ErbB signaling targets alpha7 nicotinic acetylcholine receptors to axons.

  2008cited by this paper
• First Administration of Cytidine Diphosphocholine and Galantamine in Schizophrenia: A Sustained &agr;7 Nicotinic Agonist Strategy

  2008cited by this paper
• Presynaptic Type III Neuregulin1-ErbB signaling targets α7 nicotinic acetylcholine receptors to axons

  2008cited by this paper
• Nicotinic Acetylcholine Receptors and Modulation of Learning in 4- and 27-Month-Old Rabbits

  2008influential reference
• SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

  2007cited by this paper
• Chronic Nicotine Cell Specifically Upregulates Functional α4* Nicotinic Receptors: Basis for Both Tolerance in Midbrain and Enhanced Long-Term Potentiation in Perforant Path

  2007cited by this paper
• SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

  2007influential reference
• Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation.

  2007cited by this paper
• Broad-Spectrum Efficacy across Cognitive Domains by α7 Nicotinic Acetylcholine Receptor Agonism Correlates with Activation of ERK1/2 and CREB Phosphorylation Pathways

  2007influential reference
• The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat.

  2007cited by this paper
• Sensitization to nicotine: how the animal literature might inform future human research.

  2007cited by this paper
• An Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor Possessing Cognition-Enhancing Properties in Vivo

  2007influential reference
• Alpha‐7 nicotinic acetylcholine receptor agonists selectively activate limbic regions of the rat forebrain: An effect similar to antipsychotics

  2007cited by this paper
• The α7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat

  2007cited by this paper
• Prefrontal acetylcholine release controls cue detection on multiple timescales.

  2007cited by this paper
• Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories.

  2006cited by this paper
• Microglial α7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role

  2006cited by this paper
• Indirect Modulation by α7 Nicotinic Acetylcholine Receptors of Noradrenaline Release in Rat Hippocampal Slices: Interaction with Glutamate and GABA Systems and Effect of Nicotine Withdrawal

  2006cited by this paper
• Arc/Arg3.1: linking gene expression to synaptic plasticity and memory.

  2006cited by this paper
• Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human α4β2 Acetylcholine Receptors

  2005cited by this paper
• The Selective α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide Hydrochloride] Enhances GABAergic Synaptic Activity in Brain Slices and Restores Auditory Gating Deficits in Anesthetized Rats

  2005cited by this paper
• Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.

  2005influential reference
• Regulation of activity-regulated cytoskeleton protein (Arc) mRNA after acute and chronic electroconvulsive stimulation in the rat.

  2005cited by this paper
• The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats.

  2005cited by this paper
• A Novel Positive Allosteric Modulator of the α7 Neuronal Nicotinic Acetylcholine Receptor: In Vitro and In Vivo Characterization

  2005influential reference
• Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors.

  2005cited by this paper
• Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance.

  2005cited by this paper
• Rapid Upregulation of α7 Nicotinic Acetylcholine Receptors by Tyrosine Dephosphorylation

  2005cited by this paper
• Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain.

  2004cited by this paper
• Administration of nicotine to adolescent rats evokes regionally selective upregulation of CNS alpha 7 nicotinic acetylcholine receptors.

  2004cited by this paper
• Papillary carcinoma of the thyroid: methylation is not involved in the regulation of MET expression

  2004cited by this paper
• Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long‐term but not short‐term nicotine treatment

  2004cited by this paper
• Antidepressant drug treatment induces Arc gene expression in the rat brain.

  2003cited by this paper
• Functional Mapping and Ca2+ Regulation of Nicotinic Acetylcholine Receptor Channels in Rat Hippocampal CA1 Neurons

  2003cited by this paper
• Molecular psychology: roles for the ERK MAP kinase cascade in memory.

  2002cited by this paper
• Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure.

  2002cited by this paper
• Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure.

  2002cited by this paper
• Differential effects of chronic drug treatment on α3* and α7 nicotinic receptor binding sites, in hippocampal neurones and SH‐SY5Y cells

  2001cited by this paper
• Nicotinic acetylcholine receptors containing alpha 7 subunits on rat cortical neurons do not undergo long-lasting inactivation even when up-regulated by chronic nicotine exposure.

  2001cited by this paper
• Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells.

  2001cited by this paper
• Nicotinic acetylcholine receptors containing α7 subunits on rat cortical neurons do not undergo long‐lasting inactivation even when up‐regulated by chronic nicotine exposure

  2001cited by this paper
• Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas.

  2000cited by this paper
• Inhibition of Activity-Dependent Arc Protein Expression in the Rat Hippocampus Impairs the Maintenance of Long-Term Potentiation and the Consolidation of Long-Term Memory

  2000cited by this paper
• AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.

  1999cited by this paper
• The regulation of hippocampal nicotinic acetylcholine receptors (nAChRs) after a protracted treatment with selective or nonselective nAChR agonists

  1999cited by this paper
• Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine.

  1999cited by this paper
• AR-R 17779, an α7 nicotinic agonist, improves learning and memory in rats

  1999cited by this paper
• Upregulation of Surface α4β2 Nicotinic Receptors Is Initiated by Receptor Desensitization after Chronic Exposure to Nicotine

  1999cited by this paper
• Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice

  1999cited by this paper
• Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands.

  1998cited by this paper
• Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice

  1998cited by this paper
• Chronic Nicotine Treatment Up-Regulates α3 and α7 Acetylcholine Receptor Subtypes Expressed by the Human Neuroblastoma Cell Line SH-SY5Y

  1997cited by this paper
• 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner

  1997cited by this paper
• Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.

  1997cited by this paper
• Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y.

  1997cited by this paper
• 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner.

  1997cited by this paper
• Regulation of Human α4β2 Neuronal Nicotinic Acetylcholine Receptors by Cholinergic Channel Ligands and Second Messenger Pathways

  1997cited by this paper
• Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation

  1996cited by this paper
• Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.

  1996cited by this paper
• Prolonged induction of c-fos in neuropeptide Y- and somatostatin-immunoreactive neurons of the rat dentate gyrus after electroconvulsive stimulation.

  1996cited by this paper
• Long‐term treatment with GTS‐21 or nicotine enhances water maze performance in aged rats without affecting the density of nicotinic receptor subtypes in neocortex

  1996cited by this paper
• Desensitization of the nicotine‐induced mesolimbic dopamine responses during constant infusion with nicotine

  1995cited by this paper
• Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion.

  1994cited by this paper
• Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.

  1994cited by this paper
• Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific.

  1993cited by this paper
• Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain.

  1992cited by this paper
• An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment.

  1991cited by this paper
• Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors.

  1990cited by this paper
• The paradox of nicotinic acetylcholine receptor upregulation by nicotine.

  1990cited by this paper
• Nicotine-induced tolerance and receptor changes in four mouse strains.

  1986cited by this paper
• Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.

  1986cited by this paper
• Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.

  1985cited by this paper
• Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin

  1985cited by this paper
• In Vivo Regulation of [3H]Acetylcholine Recognition Sites in Brain by Nicotinic Cholinergic Drugs

  1985cited by this paper
• The rat brain in stereotaxic coordinates: Authors: George Paxinos & Charles Watson Academic Press Australia, 1982 Softback, 154 pages (including 71 plates), 35.00 Aust $

  1983influential reference
• Effects of chronic nicotine infusion on tolerance development and nicotinic receptors.

  1983cited by this paper

• Nicotinic acetylcholine receptors in the brain.

  2025cites this paper
• The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson’s Disease

  2025cites this paper
• Exposing the latent phenotype of Gulf War Illness: examination of the mechanistic mediators of cognitive dysfunction

  2024cites this paper
• The role of nicotinic acetylcholine receptors in the pathophysiology and pharmacotherapy of autism spectrum disorder: Focus on α7 nicotinic receptors.

  2024cites this paper
• Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators

  2023cites this paper
• Adolescent nicotine administration increases nicotinic acetylcholine receptor binding and functional connectivity in specific cortico-striatal-thalamic circuits.

  2022cites this paper
• The Spinal α7-Nicotinic Acetylcholine Receptor Contributes to the Maintenance of Cancer-Induced Bone Pain

  2021cites this paper
• Evidence for Alpha7 Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough

  2021cites this paper
• N1H- and N1-Substituted Phenylguanidines as α7 Nicotinic Acetylcholine (nACh) Receptor Antagonists: Structure-Activity Relationship Studies.

  2021cites this paper
• Repeated treatment with alpha 7 nicotinic acetylcholine receptor ligands enhances cognitive processes and stimulates Erk1/2 and Arc genes in rats.

  2021cites this paper
• (E)-3-Furan-2-yl-N-p-tolyl-acrylamide and its Derivative DM489 Decrease Neuropathic Pain in Mice Predominantly by α7 Nicotinic Acetylcholine Receptor Potentiation.

  2020cites this paper
• Effect of α7nAChR on learning and memory dysfunction in a rat model of diffuse axonal injury.

  2019cites this paper
• Chemical conversion of nicotinamide into type I positive allosteric modulator of α7 nAChRs.

  2019cites this paper
• Positive allosteric modulation of the α7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury

  2019cites this paper
• Citicoline (CDP‐choline) add‐on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double‐blind, randomized placebo‐controlled trial

  2018cites this paper
• Nicotine improves probabilistic reward learning in wildtype but not alpha7 nAChR null mutants, yet alpha7 nAChR agonists do not improve probabilistic learning.

  2018cites this paper
• Alpha-7 nicotinic acetylcholine receptor agonist treatment in a rat model of Huntington's disease and involvement of heme oxygenase-1

  2018cites this paper
• New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs

  2018cites this paper
• Wheel running during chronic nicotine exposure is protective against mecamylamine‐precipitated withdrawal and up‐regulates hippocampal α7 nACh receptors in mice

  2018cites this paper
• Insights into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment

  2017cites this paper
• Perinatal nicotine treatment induces transient increases in NACHO protein levels in the rat frontal cortex.

  2017cites this paper
• Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study.

  2016cites this paper
• The positive allosteric modulator of α7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice.

  2016cites this paper
• The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

  2015cites this paper
• The Therapeutic Potential of α7 Nicotinic Acetylcholine Receptor (α7 nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia

  2015cites this paper
• Diverse strategies targeting alpha 7 homomeric and alpha 6 beta 2 * heteromeric nicotinic acetylcholine receptors for smoking cessation

  2014cites this paper
• Perinatal Hypoxia-Ischemia Reduces α7 Nicotinic Receptor Expression and Selective α7 Nicotinic Receptor Stimulation Suppresses Inflammation and Promotes Microglial Mox Phenotype

  2014cites this paper
• Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation.

  2014cites this paper
• Antidepressant activity in mice elicited by 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor.

  2014cites this paper
• Nicotinic Acetylcholine Receptor Modulators

  2014cites this paper
• Nicotinic Receptors as Targets for Novel Analgesics and Anti-inflammatory Drugs

  2014cites this paper
• Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models.

  2013cites this paper
• Regulation of expression and cellular release of acetylcholinesterase

  2013cites this paper
• Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.

  2013cites this paper
• Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism study.

  2013cites this paper
• Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment.

  2013cites this paper
• Nicotinic acetylcholine receptors: from basic science to therapeutics.

  2013cites this paper
• THE ANTINOCICEPTIVE EFFECTS OF ALPHA 7 NICOTINIC ACETYLCHOLINERECEPTOR POSITIVE ALLOSTERIC MODULATORS IN DIFFERENT ANIMAL PAINMODELS

  2012cites this paper
• The α7 nicotinic acetylcholine receptor complex: one, two or multiple drug targets?

  2012cites this paper
• α7-Nicotinic acetylcholine receptors: an old actor for new different roles.

  2012cites this paper
• Molecular Imaging of 7 Nicotinic Acetylcholine Receptors In Vivo: Current Status and Perspectives

  2012cites this paper
• Type I and II positive allosteric modulators differentially modulate agonist‐induced up‐regulation of α7 nicotinic acetylcholine receptors

  2012cites this paper
• 11C-NS14492 as a Novel PET Radioligand for Imaging Cerebral α7 Nicotinic Acetylcholine Receptors: In Vivo Evaluation and Drug Occupancy Measurements

  2011cites this paper
• Discovery and development of α7 nicotinic acetylcholine receptor modulators.

  2011cites this paper
• Ultra-low exposure to α-7 nicotinic acetylcholine receptor partial agonists elicits an improvement in cognition that corresponds with an increase in α-7 receptor expression in rodents: implications for low dose clinical efficacy.

  2011cites this paper
• Differential Immediate and Sustained Memory Enhancing Effects of Alpha7 Nicotinic Receptor Agonists and Allosteric Modulators in Rats

  2011cites this paper
• Cerebral a7 Nicotinic Acetylcholine Receptors: In Vivo Evaluation and Drug Occupancy Measurements

  2011cites this paper
• Annals of the New York Academy of Sciences Diverse Strategies Targeting ␣7 Homomeric and ␣6␤2 * Heteromeric Nicotinic Acetylcholine Receptors for Smoking Cessation

  year unknowncites this paper